INNOVATION
Seawit develops functional lipid ingredients for nutrition and specialised applications.
Our work focuses on structured lipids, Sn-2 DHA, human milk fat substitutes and related lipid technologies.
Scientific Team
Experienced experts in functional lipids, nutrition, synthetic biology and food science.
Academic Collaboration
Long-term collaboration with universities, research institutes and innovation platforms.
70+
Patents Filed
Continued innovation in functional lipid technologies.
30+
Invention Patents
Core technologies with independent intellectual property.
10+
Standards Contributed
Participation in national and industry standard development.
20+
Scientific Publications
Research published in scientific and technical fields.
Human Milk Fat Substitutes
UPU, MLCT and next-generation structured lipids designed for human milk fat research and infant nutrition applications.
Sn-2 DHA Algae Oil
Advanced Sn-2 DHA technology supporting algae-based DHA innovation and absorption research.
Structured Lipids
OPO, MLCT, MCT and customised lipid structures for targeted nutrition applications.
Microencapsulated Nutrient Powders
Nano-emulsification and encapsulation systems for stability, dispersibility and efficient delivery.
UPU / MLCT-based HMFS
Seawit pioneered UPU- and MLCT-based human milk fat substitute technologies, achieving over 90% similarity to human milk fat in validated research and advancing the next generation of infant nutrition.
Sn-2 DHA Technology
Seawit is recognised as a pioneer of human milk-like Sn-2 DHA in China. Our proprietary technology is designed to improve DHA delivery and support advanced algae-based nutrition for infants.
This market-position certification recognises Seawit as a pioneer of human milk-like Sn-2 DHA in China.
Making People Healthier
© 2026 Qingdao Seawit Life Science Co., Ltd. All rights reserved.